Fig 2. Transglycosylation reactions by Endo-S variants with significantly reduced or no detectable hydrolysis activity.
Reactions were carried out using deglycosylated trastuzumab as the acceptor and 5 molar eq of donor oxazoline.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.